SANTA ANA -- Federal prosecutors said Tuesday they're planning a third trial of an ophthalmology executive accused of insider trading, and acknowledged to the judge that it is unusual.
Assistant U.S. attorney Stephen A. Cazares said at a hearing Tuesday the evidence presented at the two previous hung trials of James Mazzo was not identical, and that four perjury charges related to Mazzo's testimony in the first trial have only been h...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In



